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S_umary Statistical analysis of published data on the age of onset of germ cell tumours of the testis and of
the prevalence of bilateral disease in familial and general cases suggest the following:
1. Patients with bilateral disease carrm the same genetic predisposition as familial cases.
2. Males with the hereditary predisposition develop none. unilateral or bilateral tumours in the proportions
55%. 38% and 7% respectively.
3. One-third of all testis cancer patients are genetically predisposed to the disease.
4. The 2.2% risk to brothers of cases as reported elsewhere can be accounted for by the homozygous
(recessive) inhenrtance of a single predisposing gene.
Keyworis: cancer: testis: heredity
The age distribution of testicular cancer is unusual in that.
after a peak incidence early in the fourth decade. the
incidence declines with advancing years. This pattern resemb-
les that of a tumour of childhood or adolescence. only set in
later years. In a small proportion of cases these tumours are
known to be familial. In the case of retinoblastoma and
Wilms tumour statistical analysis of the familial (and non-
familial hereditary) cases has provided useful information on
the molecular genesis of the malignant phenotype.
The aim of our analysis is to ascertain the incidence in the
general population of genetically predisposed germ cell tes-
ticular tumours, with a view of gaining clues to molecular
mechanisms. It is based partly on the incidence of bilateral
and unilateral cancer following the classic treatment of
Knudson (1971) for retinoblastoma. but also from a con-
sideration of the age distribution.
Although seminoma and 'teratoma' (i.e. non-
seminomatous germ cell tumour) are distinguishable his-
tologically and in some clinical features, they are both
associated with carcinoma in-situ (CIS) of testis and they can
both occur in the same individual, in different members of a
family and commonly in the same tumour. They are
therefore considered together in this study.
As with Knudson (1971). the starting point of our analysis
is that there is a simple algebraic relationship between the
probabilities of the occurrence of a random event (such as a
tumour) in neither side. in one side or both sides. A
knowledge of the ratio of the number of bilateral to
unilateral cases in those known to have a familial basis (i.e.
genetically predisposed) allows an estimate to be made of the
relative number of genetically predisposed individuals who
develop no tumour. i.e. it allows an estimate of the genetic
penetrance. to which we thereby ascribe a value of 0.45. [In
this estimate. as in other estimates, we deliberately quote
values to a greater precision (i.e. number of decimal places)
than is strictly justified by the sampling and other errors. The
purpose of this is improve clarity by allowing the reader to
follow and to verify the calculations].
In general cases (i.e. unselected in any way), bilateral
disease occurs much more frequently in patients than would
be expected by chance alone, implying that effectively all
such bilateral cases are in predisposed individuals. Com-
parison of the distribution of the age of first tumour in such
bilateral patients with that of known familial cases suggests
they share the same predisposition. General cases therefore
are essentially composed of (i) genetically predisposed
bilateral cases. (ii) genetically predisposed unilateral cases
and (iii) sporadic unilateral cases. The ratio between (i) and
(ii) can be inferred from data onfamilial cases which, in turn,
allows (iii) to be estimated. From this we estimate that 33%
of all general cases are genetically predisposed.
Using this model (i.e. 33% of general cases are genetically
predisposed. and individuals with the genetic predisposition
have a penetrance of 0.45). we examine simple modes of
inheritance of a single gene in order to account for the risk to
sons and fathers of cases which have been reported
elsewhere.
Dmhic
Bilateral testicular germ cell tumours
In bilateral disease the median interval between presentation
of the two tumours is about 5 years (Dieckmann et al., 1986;
Von der Maase et al., 1986; Osterlind et al.. 1987) although
this may be an underestimate as many of these bilateral cases
will be under-reported owing to lack of exhaustive follow-up.
When the duration of follow-up is known, allowance can be
made but it is generally not reported. In addition, second
tumour development may be prevented by treatment or by
death.
When, at the time of initial diagnosis of testis cancer, a
biopsy of the contralateral testis is carried out, the presence
or absence of carcinoma in situ (CIS) reliably predicts future
tumour development (Giwercman et al.. 1993). Thus testis
biopsy offers a means for assessing the prevalence of bilateral
disease avoiding the problems referred to above.
CIS of the contralateral testis was reported in 34/600
patients (5.7%) (Von der Maase et al.. 1987) and 54,1,188
(4.5%) patients (Loy and Dieckmann, 1993). Thus, out of
1.788 patients, 87 (4.9%) showed CIS and may be assumed
to be potential bilateral cases. Dieckmann et al. (1993) comp-
rehensively surveyed the literature where the criterion of
bilaterality was actual presentation of the second tumour.
Out of a total of 10.235 cases, the number of bilateral
tumours reported was 267 (2.610%). implying under-reportage
by a factor of about 2.
Information on the age distribution of bilateral cases
occurring since 1945 was taken from 15 published reports as
detailed in Table I. Patients under the age of 5 were excluded
(one case) as in this case disease may occur by a different
mechanism. The age distributions are approximately normal
and so a one-way analysis of variance was carried out to test
whether the cases from the 15 sources had reasonably consis-
tent mean ages. The result of this analysis showed that,
although there was a statistically significant (at P<0.05)
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amount of variation between the sources, it was small in
magnitude. The estimated between-source s.d. in age was 2.8
years. whereas the estimated within-source s.d. was 9.0 years.
In view of the diverse origins of the 15 sources the between-
source variation was surprisingly small so the 139 cases were
pooled. The mean (s.d.) age was 30.1 (9.4 years), and the
distribution with age category is included in Table II and
plotted in Figure 1.
Familial cases
Very few data have been reported on the fraction of con-
tralateral CIS in familial cases, and so an estimate must be
based on the actual presentation of the second tumour.
Dieckmann et al. (1987) summarised earlier reports of
familial germ cell tumours and found 14 bilateral cases out of
173. Forman et al. (1992) reported a corresponding figure of
five cases out of 86. Thus, out of a total of 259 cases, the
number of bilateral cases was 19 (7.3%). As noted earlier,
this bilateral fraction is almost certainly an underestimate. If
the extent of this is the same as in the general population,
then the number of familial bilateral cases would be doubled.
giving a fraction of cases of 14.7%. Although most of our
subsequent analysis is based on the assumption of a value of
14.7%. we also give results for the assumption of a value of
7.3%, termed the 'alternative assumption'. Some evidence on
the magnitude of the familial bilateral fraction is available
from a consideration of mean age of tumour presentation
and is given in the Analysis section.
The ages of familial cases occurring since 1945 of age 5
and over (in fact none under this age had been reported)
were derived from the two sources cited above. Fathers were
excluded on the basis that men who contract a testicular
tumour late in life are more likely to father children and so
may be over-represented. The survey of Dieckmann et al. is a
Table 1 Mean and s.d. of age of occurrence of first testicular
tumour in individuals who progress to bilateral disease and of
familial cases
Mean s.d. n Reference
Bilateral cases
44.0 22.0 5 Ehrengut et al. (1980)
32.5 9.4 8 Hoekstra et al. (1982)
27.7 7.7 6 Ware et al. (1982)
28.3 7.6 11 Bach et al. (1983)
25.6 6.9 7 Strohmeyer and Hartmann (1984)
23.3 5.5 4 Csapo et al. (1987)
28.9 6.1 20 Scheiber et al. (1987)
28.1 8.5 9 Thompson et al. (1988)
26.9 6.4 14 Wahl and Hedinger (1988)
35.0 5.5 4 Barth and Krauss (1989)
34.5 13.5 15 Patel et al. (1990)
32.0 3.2 5 Dieckmann et al. (1993)
29.1 5.4 9 Dieckmann et al. (1986)
28.4 9.3 14 Fossa and Aass (1989)
33.4 8.5 8 Von der Maase et al. (1987)
All bilateral cases
30.1 9.4 139
Familial cases
29.7 8.3 127 Dieckmann et al. (1987)
28.1 6.5 69 For-man et al. (1992)
All familial cases
29.1 7.7 196
summary of many earlier reports. each often detailing only
two cases, so it was impracticable to carry out an analysis of
variance over all the primary sources. However, an analysis
of variance between the cases surveyed by Dieckmann et al.
(1987) (127 in number) as a whole and those reported by
Forman et al. (1992) (69 in number) was carried out. No
significant variation between the two groups was detected
(P>0.1) and so the cases, 196 in all, were pooled and had a
mean (s.d.) age of 29.1 (7.7). Their distribution with age
category is included in Table II and is plotted in Figure 1.
Generalpopulation
The incidence of general cases (i.e. not selected on the basis
of familial occurrence) of testicular tumours varies con-
siderably between countries, and in some, notably Denmark,
rates have shown a considerable increase over the last 30
years. For the present purposes we ideally require a represen-
tative population which matches the countries and time
periods for which the bilateral and familial cases were
reported. Table III shows the age-specific incidence rates of
testicular cancer for some selected countries where data col-
lection may be assumed to be reasonably efficient. Data for
Denmark is included for two periods, 1953-57 and 1973-76,
between which the incidence rates almost doubled. For these
two time periods the rates were converted into numbers of
cases by a standard European age structure (Doll et al.,
1966). In spite of a near-doubling of incidence, no difference
between the distributions of age-specific numbers of the two
time periods could be detected (Kolmogorov-Smirnov test,
P = 0.79). The mean and s.d. of the resulting ages are given
in Table III and, as the data are only available for 5 year age
intervals, cases were assigned an age at the mid-point of the
corresponding interval. Table III shows that the mean and
s.d. are very similar over the two time periods for Denmark,
and for the other two regions shown.
The data above are for cases which included primary
lymphomas, the contribution of which is significantly greater
at later ages. For the purpose of this paper it was necessary
to use data relating to germ cell tumours only, and this has
been published for the UK by the Testicular Tumour Panel
(Pugh, 1976). The age distribution of 1,527 cases is given in
Table II and Figure 1, and has a mean (s.d.) of 35.7 (11.4).
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Figue 1 Distribution of age of first tumour presentation (AFTP)
in 139 bilateral cases (0), 196 familial cases (*) and 1527
general cases (-) of testicular germ cell cancer.
Table H Age distributions
Key2 5-9 10-14 15-19 20-24 25- 9 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75- 79 80-84 Total
A 0 0 10 29 42 25 15 5 6 4 2 0 0 1 0 0 139
B 0 2 10 53 50 34 23 15 8 1 0 0 0 0 0 0 196 C 4 6 51 178 272 268 245 170 139 96 55 21 12 3 6 1 1527
A. age of onset of first tumour in bilateral cases; B, age of onset of first tumour in familial cases; C. age of onset for all germ cell tumours from the British Testicular Tumour Panel (Pugh. 1976).
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Table In Mean and s.d. of age of occurrence of testis tumours over the age range
5-84
Number of
Source cases Mean s.d. ASR
Denmark 1953-57 (Doll et al.. 1966) 438 38.7 13.7 4.1
Denmark 1973-76 (Waterhouse et al.. 1982) 718 38.6 13.1 7.2
Hamburg and Saarland, W. Germany 595 36.8 14.0 5.4
1973-82 (Waterhouse et al.. 1982; Muir
et al.. 1987)
England and Wales 1979-82 (Muir et al.. 3.380 37.1 13.0 3.5
1987)
UK Germ cell tumours (Pugh. 1976) 1.527 35.7 11.4
Bilateral tumour group 139 30.1 9.4
Familial tumour group 1% 29.1 7.7
For the first four rows the values were calculated from the reported age-specific incidence
rates of all (i.e. including non-germ-cell) testis tumours applied to an age distribution of a
notional European population (Doll et al.. 1966). ASR. age-standarised rate per year per
100000.
ABaysis
Genesis ofthe contralateral tumours
If the age-standardised rate of typical W. European individ-
uals acquiring one or more tumours is assumed to be 5 per
100,000 per year (see Table III), this corresponds to a lifetime
risk over 70 years of 0.35% or 1 in 286. Assuming that
tumongenesis in the two sides proceeds independently, this
means a lifetime probability of 0.175% per testis. Of individ-
uals who acquire a tumour in one side, 0.088% would be
expected to acquire a tumour in the other testis (see Appen-
dix). When account is taken of the likely shorter life span of
such persons the expected bilateral fraction would be reduced
still further. Clearly therefore this explanation can only
account for a very small part of the 4.9% of cases which are
bilateral.
Two explanations of the existence of the large bilateral
fraction offer themselves. The first is that tumorigenesis does
not proceed independently in the two sides. This would be
the case if the contralateral tumour were a metastasis of the
first tumour. However, the very high association of these
invasive testicular tumours with intraepithelial neoplasia
confirms their primary origin. The second explanation is that
the general population is not homogeneous for the risk of
germ cell neoplasia, and there exists one or more subpopula-
tions of subjects who are predisposed to both unilateral and
bilateral forms. This predisposition may be genetic or
environmental, and although the operation of an
environmental predisposition cannot be completely ruled out,
it is the purpose of this paper to explore whether the oper-
ation of a genetic predisposition alone can adequately
account for the observations.
Genetic predisposition in testis cancer
If a subpopulation with a genetic predisposition exists, we
take the simplest assumption, namely that all such cases have
a common malignant genotype which, furthermore, is the
same as in cases known to have a familial basis.
In familial cases the magnitude of the bilateral fraction
would appear to be about 14.7% (see earlier section), giving
a ratio, R, of bilateral to unilateral cases of 14.7,
(100- 14.7) = 0.172. It is shown in the Appendix that the
expected ratio of individuals who do not develop any tumour
to those who are unilateral cases is 1/(4R), i.e. 1.44. These
values for the ratios lead to the proportions of 0.554, 0.381
and 0.065 for the numbers of individuals with the malignant
genotype who would develop no tumour, unilateral tumours
and bilateral tumours respectively, and so the genetic penet-
rance would be 0.45. In fact, a small fraction of cases
reported as 'familial' would have occurred by chance. i.e. be
sporadic. However, the relative risk for a brother for testis
cancer has been shown to be about 9.8 (Forman et al., 1992)
and so in the calculation above we have ignored any correc-
tion for such contamination by a sporadic component.
In general cases (i.e. those not selected in anv way).
bilateral disease occurs in 4.9% of the cases, and we have
hypothesised that, apart from a very small minority, these all
arise from a subpopulation of individuals with the malignant
genotype. We also assume that the genotype of this sub-
population is the same as that of familial cases. It follows
that the subpopulation would have numbers in the bilateral
and unilateral categories in the same ratio as that observed
(i.e. 0.172) in the familial cases. Thus. in general cases. the
4.9% of these which are observed to be bilateral (all essen-
tially in individuals with the malignant genotype) would be
expected to be accompanied by a further 4.9 0.172 = 28.5%
unilateral cases with the malignant genotype. A total of
33.4% of all general cases are expected to be from individ-
uals with the malignant genotype; the balance. 66.6%. of
general cases are therefore tentatively assigned as sporadic
unilateral cases. Figure 2 gives a summary chart of the above
reasoning.
These estimates are obviously subject to some uncertainty.
stemming mainly from the estimate of the familial bilateral
fraction which included an arbitrary allowance for under-
reporting. as well as sampling error. Although we presented
evidence why such an allowance was reasonable (see Demo-
graphics section) it is of interest to examine the consequence
of its omission (the 'alternative assumption'). Under the alter-
native assumption the familial bilateral fraction would be
7.3% and this, following the same path of reasoning as
before. leads to an estimate of penetrance of 0.25 and a
fraction of 67% (as against 33.4% on our previous assump-
tions) of all general cases being in individuals with the malig-
Individuals with malignant genotype
6.5% 38.1%
Unilateral
X
m
Ratio
,'0.172: 1
11 1 J ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I I,
55.4%
From data
No tumour on
familial
cases
General cases
Unilateral Unilateral (Malignant (Sporadic)
genotype)I
4.9% 28.5%
Observed
Fgre 2 Summary of model.
66.6%
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nant phenotype. Some eVidence that such a large fraction is
unlikely is presented later.
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Is the predisposition in general cases the same as that in
familial cases? The age offirst tumour presentation (AFrTD
An implicit assumption in the foregoing analysis is that the
two groups (a) all familial cases and (b) the bilateral cases
among general cases have the same malignant genotype.
Some examination of this assumption can be provided by a
consideration of the age distribution of the first tumour.
However, in order to do this it is first necessary to take into
account biases in the data collection process.
Figure 1 shows the distribution of the age of first tumour
presentation (AFTP). whether a second tumour develops or
not. for familial cases and is based on pooled data for all
brothers and sons. fathers being excluded on the basis that
men who contract a testicular tumour early in life are less
likely to father children and so may be under-represented.
Most of the data were collected on the basis of an individual
case, the proband. who was identified as familial through
having a brother with a history of a tumour. Compared with
the AFTP of unselected cases it would be expected that, for
proband-brother pairs, the AFTP of a proband's brother
would be biased to earlier ages (as. in most reports, the pair
came to attention because of an earlier tumour in the pro-
band's brother). Similarly, the AFTP of the probands would
be biased to later ages. We could not analyse the AFTP of
brother and proband separately as most reports do not iden-
tify which of the pair is the proband. However, if each
proband-brother pair were assumed to have similar birth
dates, it can be shown that. when the AFTPs of probands
and brothers are pooled, these biases cancel out. Realistically
the difference in birth date in proband-brother pair will not
be zero, but the mean difference would be near to zero, and
so the same conclusion would appear to hold good.
In view of the foregoing, a direct comparison of the AFTP
distribution of the familial group [n = 196, mean (s.d.) 29.1
(7.7) years] with that of general cases [n = 1,527. mean (s.d.)
35.7 (11.4) years] seems fair. In such a comparison (Figure 1)
it will be observed that the distributions appear quite
different; the mean AFTPs have a highly significant
difference (t = 10.6, P< 10-6, d.f. = 1.721).
The question of direct interest for our hypothesis, however.
is whether the AFTP distribution of bilateral cases is com-
patible with that of familial cases. Bilateral cases, compared
with unselected (i.e. regardless of eventual laterality) cases
from the same population. are more likely to be over-
represented when the first tumour occurs at an early age
because patients are thereby at risk of developing a second
tumour for longer. It is possible to compute, from an
assumed AFTP distribution of unselected cases from a sub-
population, what the AFTP distribution would be for those
individuals who eventually progress to bilaterally. Most
bilateral data are collected with a limited follow-up period,
and the computation needs to take this into account. In the
Demographics section a comparison was made between the
incidence of bilateral CIS and that of the reported bilateral
tumour presentation. The difference was interpreted as due to
incomplete ascertainment of almost half the cases. As the
median time to bilateral tumour is about 5 years. it seems
reasonable to take this as the representative follow-up period.
Figure 3 shows, for bilateral cases, the observed AFPT dist-
ribution together with the projected AFPT distribution
derived from the AFTP distribution of (i) general cases
(Figure 1) and (ii) familial cases (Figure 1). The projections
based on a 10 year follow-up period are also plotted in
Figure 3, and it will be observed the outcome is not unduly
sensitive to its value. Figure 3 shows that the observed AFTP
distribution of bilateral cases matches much more closely the
projected distribution derived from familial cases rather than
that derived from general cases. Although there is not a
perfect match, the similarity of the AFPT distnrbution of
bilateral cases and that projected from the AFTP distribution
of familial cases is probably as good as can be expected
30
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Figure 3 Distribution (0) of age of first tumour presentation
(AFTP) observed in 139 bilateral cases. Also shown are projected
distributions calculated from the AFTP in general cases (A and
A) and in familial cases (O and *). where the open and closed
symbols correspond to a follow-up penrod of 5 and 10 years
respectivelv.
considering that the bilateral data were collected under
diverse conditions and so may be subject to other biases.
An upper limit to the proportion ofhereditarY cases
The general cases contain a proportion of hereditary cases,
the balance being sporadic cases. While it is not possible
independently to infer a magnitude for this proportion from
a consideration of age distribution alone (since the age dis-
tribution of the sporadic cases is unknown), it is possible to
set an upper limit to it. First note that out of 196 familial
cases, 65 have an age in the range 5 -24 years (Table II) For
simplicity consider 1,000 general cases having the age dist-
ribution also detailed in Table II: 156 of these would be
expected to occur in the age range 5-24 years. Suppose now
that hereditary cases were to constitute 50% of the general
cases then these alone would contribute 166 ( = 65 x 50/
196). and as yet no account has been taken of the contribu-
tion from the sporadic fraction. This type of reasoning.
though not exact, suggests that the contribution from
hereditary cases to the general cases cannot be more than
47%, and so lends some credence to the assumption of a
value of 33.4%.
Risk to brother andfathers of cases
Forman et al. (1992) reported a case-control study in which.
out of 794 testicular cancer patients in the UK, eight cases
had a brother with a previous diagnosis of testicular cancer,
compared with one individual in a control group. This is
broadly in line with three earlier studies (Henderson et al..
1979; Tollerud et al., 1985; Dieckmann et al., 1987) in which
a total of six cases out of 584 were reported as having
brothers with a previous diagnosis. Using actuarial analysis
to take account of numbers of brothers at risk to an age of
50 years, Forman et al. (1992) calculated the risk to brothers
of cases as 2.2% (95% confidence interval 0.6-3.8%).
For fathers of cases, Forman et al. (1992) reported the
number of cases as 4 from 794 cases as against 1 from 794
controls. The three earlier studies reported four affected
fathers of 584 cases. Forman et al. point out that a proper
estimate of risk to fathers is difficult to calculate owing to
limitations in the cancer registration data prior to 1950.
However, even with this in mind, together with the absence
of any allowance for follow-up in fathers, the proportion of
affected fathers 7 1,378, i.e. 0.5%, appears to be less than the
risk (2.2%) to brothers. Some of this may be accounted for
by the reduced fertility and premature death of potential
fathers carrying the malignant genotype.
4
424Heterozygous (dominant) malignant genotype On the as-
sumption that the inherited malignant genotype is a heter-
ozygous form of a single gene with two possible alleles, the
probability of a brother, or of a father, also carrying the
malignant genotype would be essentially 4. Our model
(Figure 2) suggests that 33.4% of all cases occur in individ-
uals with the malignant genotype and are the product of a
penetrance of 0.45. Some of these may be non-familial indi-
viduals (i.e. in whom a parental germ cell mutation occurred
since the previous generation), but we will assume initially
that these are negligible. The projected risk to the brother, or
the father, of a case is then 0.334 x 0.45/2, i.e. 7.5%. This is
clearly much larger than that indicated (2.2%) by the demo-
graphic data for brothers. [Under the alternative assumption
(see Demographics section) the projected risk to a brother or
father would be 8.3%.]
If a significant fraction of individuals with the malignant
genotype were new germline mutations, this would revise
downwards the projected risk to brothers and fathm. How-
ever, to bring the projected risk to brothers into line with the
2.2% reported would require the assumption that only 30%
of all individuals with the malignant genotype would be
familial, as opposed to hereditary non-familial (new mutation
in parental germ ine). This seems unlikely on two counts.
First, with an overall assumied incidence of germ cell tumours
of I in 286, the incidence of individuals with the malignant
genotype would be (1/286) x 0.334/0.45, i.e. 2.6 x 10-3, and
the allek frequency would be half this, i.e. 1.3 x 10-3.
Seventy per cent of these would have to be new mutations,
i.e. 1,000 per 106 genes per generation. This is much larger
than values reported elsewhere: corresponding mutation rates
per 10' genes for achondroplasia, retinoblastoma, polyposi
coli and neurofibromatosis are 14, 20, 20 and 100 respectively
(Emery and Mueller, 1992). Secondly, if equilibrium between
mutation and selection may be assumed, the proportion of
non-familial cases out of all cases with the malignant
phenotype would be 1- s, where s is the selection coefficient
(Crow, 1986). (1 - s is the ratio of the number of offspring
with a parent who has the malignant genotype to that of
normal parents.) Assuming selection only applies when the
father is the carrier, and that his fertility is then reduced to
half, the value of s would be 0.25 and so the assumption of
equilibrium would require a proportion of 75% of individ-
uals with the malignant genotype to be familial.
Similar considerations apply to the projected risk to
fathers. The assumption of heterozygous inheritance gives an
even greater dicrepancy between the projected risk to fathers
and the proportion of affected fathers of cases (0.5%)
although, as noted earlier, the latter figure is based on scanty
information.
Homozygous (recessive) malignant genotype If the inherited
malignant genotype were the homozygous form of a single
gene with two possible alleles, the affected offspring would
mainly be the product of two heterozygous parents and, of
such parents, one in four sons would have the malignant
genotype. Assume initially, as before, that the non-familial
fraction is negligible. The projected risk to a brother is then
0.334 x 0.45/4, i.e. 3.75%. This is just consistent with the
reported risk of 2.2% (95% confidence interval 0.6-3.8%).
[Under the alternative assumption (see Demographics sec-
tion) the projected risk to a brother would be 4.2%.]
The incidence of individuals with the malignant genotype
was esimated at (1/286) x 0.334/0.45, i.e. 2.6 x 10-3, or ap-
proximately 1/400. Assuming the malignant genotype is a
homozygous state, the allele frequency is therefore the square
root of this, 1/20. It follows that approximately 1/20 of all
homozygotes would be the product of a homozygous father
and heterozygous mother, the rest being almost entirely the
product of two heterozygous parents. With a penetrance of
0.45, it follows that the projected risk to a father of a
randomly seleted case would be 0.334 x (1/20) x 0.45, i.e.
0.75%. If account were taken of the reduced fertility of
homozygous fathers, this projected value would be revied
downwards somewhat. It will be observed that this is similar
PW Nhls ad SJ Haid
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to the approximate estimate (0.5%) of risk to the father of a
case. [Under the alternative assumption (see Demographics
section) the projected risk to a father would be 1.6%.]
The assumption was made above that the non-familial
proportion was small. This seems reasonable as the allele
frequency of 1/20, i.e. 50,000 per 106 is much greater than the
gene mutation rates (given earlier) that have been reported
for other inherited conditions.
We have argued that, as the fraction of bilateral cases is
much larger than that accounted for by chance in a
homogeneous population, there must be a predisposed sub-
population. As the distribution of age of onset of the first
tumour in bilateral disase is similar to that seen in familial
cases, and is unlike that seen in general cases, we have
assumed that the predisposition is genetic. The ratio between
bilateral and unilateral disease in familial cases is estimated
at 0.172 and implies a genetic penetrance of 0.45. Application
of this same ratio to the general testis cancer population
leads to the estimate that 33.4% of these are hereditary
(Figure 2). This in turn allows us to predict the risk to
brothers and fathers of cases on the assumption of
inheritance of a single predisposing gene. If the predisposing
gene is assumed to be inherited in homozygous form the
projected risk to brothers and fathers is broadly in line with
that reported elsewhere.
Our analysis is based on data which was collected under
diverse conditions over many years and depends in part on
small numbers of cases. As with any retrospective analysis it
is impossible to take account of unsuspected biases which
probably are of greater importance than sampling error. The
assumptions we have made which underlie the model may be
wrong. Thus, it may be that certain unilateral cases are
predisposed to a contralateral tumour by some unsuspected
biological mechanism, or that there is more than one predis-
posed subpopulation of individuals, or that the mode of
inheritance is of a more complex nature, involving more than
one gene or genomic imprinting. However, we base our
analysis on the simplest possible set of assumptions which fit
the data reasonably well.
If the assumption that the malignant phenotype is a
homozygous state is correct, the allele frequency is estimated
at about 1/20. This implies that the incidence ofheterozygous
individuals in the general population would be 1 in 10. It is
tempting to speculate that some, or indeed alL, of 'sporadic'
cases may be in these heterozygous individuals. Thus, these
'sporadic' cases may in fact be the product of a heterozygous
predisposition together with a low penetrance, ofthe order of
0.023 or klss. Such a low penetrance would ensure that
essentially all such cases would be unilateral and so would
not invalidate the assumptions of our analysis. It is of
interest that the 129 strain of mice shows just such a pattern
of inherited predisposition to testicular teratoma for the Ter
gene in both homozygous and heterozygous form (Noguchi
and Noguchi, 1985).
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Appoix
If p is the probability of one or more tumours in either side, the
probability of no tumour in either side is (I-p)2, the probability of
unilateral tumour is 2p(l -p) and of bilateral tumours is j2. Thus
the ratio of probabilities of bilateral to unilateral tumour is
p/(2 - 2p) = R, say, and the ratio of probabilities of no tumour to
unilateral tumour is (1-p)/(2p) = 1/(4R). These relationships assume
statisfical independence between tumonrigenesis on the two sides, but
do not require any other assumption about the nature ofthe process.iiunm md bsw cancer
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